Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)

Recruiting now · Not applicable

Conditions studied: Hereditary Cancer Syndrome

In brief

The goal of this clinical trial is for researchers to compare the effectiveness of a mainstreamed model of genetic testing (MGT) with an enhanced standard of care model (SOC+) on the uptake of genetic testing among at-risk patients in an urban Federally Qualified Health Center (primary care) setting using a hybrid-effectiveness study design. Aim 1 is to compare the effectiveness of MGT and SOC+ interventions on the uptake of genetic testing among patients receiving primary care in an urban federally qualified health center (FQHC) system using a randomized trial study design. The hypothesis is that the uptake of testing will be higher among patients receiving services through the MGT compared with the SOC+ model. Aim 2 is to evaluate the implementation outcomes (acceptability, feasibility and sustainability) and the barriers and facilitators of cancer genetic service delivery approaches within primary care at FQHCs via qualitative interviews with patients, primary care providers and clinic staff, and organizational leaders, guided by the Explore, Prepare, Implement, Sustain (EPIS) implementation framework. The study will take place at four community health clinics that are part of a Federally Qualified Health Center (FQHC) network in Chicago. Each clinic will use one of two ways of providing cancer genetic services: an enhanced standard of care model that includes patient navigation support (SOC+), or a mainstream genetic testing model (MGT) in which primary care providers offer testing directly. Information such as patients' demographic characteristics, referrals for genetic counseling, completion of genetic testing, and how long it takes to complete testing will be collected from clinic records. Patients, healthcare providers, and clinic staff will also be invited to take part in interviews to share their experiences and perspectives on how each model worked in practice.

Key facts

Study ID

NCT05664867

Run by

University of Illinois at Chicago

People needed

80

Starts

2022-08-01

Expected to finish

2027-06-01

Last updated by the study team

2026-01-14

Who can join

Age: 25 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Did not meet the inclusion criteria
• Did not screen positive on HCRA and/ or did not agree to have study staff contact them in the future to participate in virtual/telephone interviews about their experiences with cancer genetics services.
• Not a patient receiving care from the one of the clinics enrolled in the clincial trial
• Aim 2
• Inclusion Criteria for Providers/Staff:
• Provider or staff member at one of the 4 clinics participating in the clinical trial
• English speaking
• Exclusion Criteria:
• Does not meet inclusion criteria above

Where it is running

• University of Illinois Cancer Center — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.